Chapter 2
Understanding how weightlessness transforms every system in the human body
Microgravity, often called weightlessness or zero-gravity (though technically incorrect), is perhaps the most defining characteristic of spaceflight. On the International Space Station, astronauts experience approximately 90% of Earth's gravitational force, but because they are in continuous free fall around Earth, they feel weightless. This absence of the constant gravitational load that our bodies evolved to handle triggers a cascade of physiological adaptations—some beneficial, most detrimental.
Within seconds of reaching orbit, the body begins adapting. Fluids shift headward, the cardiovascular system recalibrates, and mechanoreceptors that normally sense weight begin sending altered signals to the brain. Over the following days, weeks, and months, more profound changes occur: bones demineralize, muscles atrophy, the immune system is suppressed, and even gene expression patterns shift.
On Earth, gravity pulls approximately 2 liters of blood and interstitial fluid into the lower extremities. This hydrostatic gradient is so fundamental that our cardiovascular system has evolved sophisticated mechanisms to pump blood upward against gravity. In microgravity, this gradient disappears within hours.
| Body Region | Earth Baseline | Microgravity Change | Physiological Effect |
|---|---|---|---|
| Lower Legs | ~900 mL fluid | -500 to -700 mL | Reduced leg circumference, "bird legs" |
| Head/Neck | Baseline | +400 to +600 mL | Facial puffiness, nasal congestion |
| Thorax | Baseline | +200 to +300 mL | Increased central blood volume |
| Total Blood Volume | ~5 liters | -10% to -17% | Hemoconcentration, reduced plasma |
The immediate consequences are familiar to anyone who has seen astronauts in orbit: puffy faces, narrowed airways causing nasal stuffiness, and thin legs. Baroreceptors in the carotid arteries and aortic arch sense the increased upper body fluid volume as "hypervolemia" and signal the kidneys to excrete fluid. Over the first few days, astronauts lose 10-17% of their blood volume, primarily from plasma reduction.
This fluid shift and volume reduction have serious implications for return to Earth. When astronauts land, gravity suddenly pulls blood downward again, but their reduced blood volume and deconditioned cardiovascular system struggle to maintain cerebral perfusion. The result is orthostatic intolerance: dizziness, fainting, and inability to stand without assistance. Longer missions produce more severe orthostatic intolerance, with some astronauts unable to stand for more than a few minutes after landing.
Perhaps no physiological change in microgravity is more concerning than bone loss. On Earth, bones constantly remodel in response to mechanical loading. Osteoblasts build new bone while osteoclasts resorb old bone, maintaining a delicate balance. In microgravity, this balance is disrupted catastrophically.
Weight-bearing bones—particularly the lumbar spine, hip, femur, and calcaneus (heel bone)—lose density at rates of 1-2% per month. This is equivalent to 10-20 times the annual rate of postmenopausal osteoporosis. A six-month ISS mission can result in bone mineral density losses of 5-15% in critical skeletal sites.
| Skeletal Site | Loss Rate (%/month) | 6-Month Loss | Recovery Time (months) |
|---|---|---|---|
| Lumbar Spine | 1.0 - 1.5% | 6 - 9% | 24 - 48 |
| Femoral Neck | 1.5 - 2.5% | 9 - 15% | 36 - 60 |
| Trochanter | 1.5 - 2.0% | 9 - 12% | 30 - 48 |
| Pelvis | 1.0 - 1.5% | 6 - 9% | 24 - 42 |
| Calcaneus | 1.5 - 2.0% | 9 - 12% | 30 - 48 |
The mechanism is complex but centers on reduced mechanical loading. Osteocytes—cells embedded in bone matrix—sense mechanical strain and signal osteoblasts to build new bone. In microgravity, strain is minimal, osteoblast activity plummets, and osteoclast activity continues or even increases. Calcium and phosphorus are released into the bloodstream and excreted in urine, increasing kidney stone risk.
While bone density gradually recovers after spaceflight, studies show that some astronauts never fully regain pre-flight bone mass. A three-year Mars mission could result in 20-30% bone loss in critical sites, potentially causing permanent skeletal fragility and increased fracture risk. This is a major concern for exploration missions and has driven intensive research into countermeasures.
Muscles, like bones, require constant loading to maintain mass and strength. In microgravity, postural muscles that normally fight gravity 16 hours a day suddenly have no work to do. The result is rapid atrophy, particularly in antigravity muscles: calves (soleus and gastrocnemius), quadriceps, back extensors, and gluteals.
Studies show that without countermeasures, astronauts can lose up to 20% of muscle mass on a six-month mission, with losses as high as 40% in specific muscle groups. The soleus muscle, a slow-twitch postural muscle in the calf, is especially vulnerable. Muscle strength declines even more dramatically than mass, with some astronauts showing 30-40% reductions in leg strength.
Microgravity not only causes muscle atrophy but also changes muscle fiber composition. Slow-twitch Type I fibers (built for endurance) convert toward fast-twitch Type II fibers (built for power but fatigued quickly). This shift, combined with mitochondrial dysfunction and reduced capillary density, impairs aerobic capacity and endurance.
The loss of muscle mass and strength has serious functional consequences. Astronauts arriving at Mars after a 6-9 month transit would have severely compromised ability to perform physically demanding tasks like climbing ladders, operating equipment, or responding to emergencies. This has driven the development of exercise countermeasures that are now mandatory on ISS.
The cardiovascular system undergoes substantial remodeling in microgravity. Without gravitational stress, the heart doesn't have to work as hard to pump blood throughout the body. Over weeks and months, this leads to cardiac atrophy—the heart muscle literally shrinks. Studies using echocardiography show decreases in left ventricular mass of 10-15% on long-duration missions.
Additionally, blood vessels lose tone. Arterial walls become less elastic, and the baroreflex—the rapid adjustment of heart rate and blood pressure in response to position changes—becomes blunted. Maximum aerobic capacity (VO₂max) decreases by 15-25%, reducing exercise tolerance and overall fitness.
While rare, cardiac arrhythmias have been documented during spaceflight, particularly during extravehicular activities (EVAs) when physical exertion is high. The combination of cardiovascular deconditioning, electrolyte shifts, stress, and physical demands can trigger abnormal heart rhythms. Continuous monitoring and emergency protocols are essential safeguards.
Spaceflight causes significant changes to the immune system, a phenomenon termed "spaceflight-induced immune dysregulation." Multiple mechanisms contribute:
The exact mechanisms are still being elucidated but likely involve stress hormones (cortisol, catecholamines), altered circadian rhythms, radiation exposure, microgravity effects on immune cell trafficking, and changes in the microbiome. This has implications for long-duration missions where astronauts cannot easily receive advanced medical care.
Recent research has revealed that microgravity affects biology at the most fundamental levels—cells and molecules. Gene expression patterns shift, with changes in thousands of genes related to metabolism, DNA repair, immune function, and stress responses.
Mitochondria, the powerhouses of cells, show functional changes including reduced oxidative capacity and increased production of reactive oxygen species (ROS), potentially accelerating aging. Cell membrane properties change, affecting how cells sense and respond to their environment. Even telomeres—protective caps on chromosomes that shorten with age—show alterations during spaceflight, though the long-term implications remain unclear.
The NASA Twins Study revealed that Scott Kelly's telomeres actually lengthened during his year in space, contrary to expectations. However, they shortened rapidly upon return to Earth, ultimately becoming shorter than baseline. Gene expression changes affected over 90% of genes in some categories, with many returning to normal but some showing persistent alterations months after landing.
Understanding these physiological changes has driven the development of countermeasures—interventions designed to minimize deconditioning:
Current countermeasures are partially effective. Modern exercise protocols have significantly reduced muscle and bone loss compared to early missions, but they cannot completely prevent deconditioning. For Mars missions, more effective countermeasures—potentially including artificial gravity—will be essential.